Home
Latest Filings
Latest Buys
Latest Sells
Institutions
Derivatives
Hot Buys
Data Screener
Email Alerts
Insider Charts
KEM
- As of 09/22/24, 04:25:39 AM: 31 Insider Transactions.
Sector:
Technology
Industry:
Diversified Electronics
Prev Close:
$2.99
Avg Vol(3m):
117,108
P/E:
0.00
EPS:
-1.17
Email this page to a friend.
Insider Transactions for KEM
Buy/Sell*
Filed Date
Subject
Symbol
Acquirer
Pct Owned
Details
B
2020-05-11 16:26:01.0
KEMET CORP
KEM
ARP AMERICAS LP
5.27%
view
S
2020-02-12 11:25:39.0
KEMET CORP
KEM
DIMENSIONAL FUND ADVISORS LP
5.25%
view
S
2020-02-12 11:13:22.0
KEMET CORP
KEM
VANGUARD GROUP INC
6.22%
view
B
2020-01-24 12:33:10.0
KEMET CORP
KEM
GOLDMAN SACHS GROUP INC
5.4%
view
B
2020-01-16 15:08:18.0
KEMET CORP
KEM
ARP AMERICAS LP
5.23%
view
S
2020-01-02 14:56:20.0
KEMET CORP
KEM
Magnetar Financial LLC
4.98%
view
B
2019-11-27 16:30:42.0
KEMET CORP
KEM
Magnetar Financial LLC
5.24%
view
S
2019-02-12 18:59:06.0
KEMET CORP
KEM
RENAISSANCE TECHNOLOGIES LLC
3.99%
view
S
2019-02-11 13:55:04.0
KEMET CORP
KEM
VANGUARD GROUP INC
6.25%
view
S
2019-02-08 08:24:36.0
KEMET CORP
KEM
DIMENSIONAL FUND ADVISORS LP
5.28%
view
S
2019-01-31 14:08:13.0
KEMET CORP
KEM
BlackRock Inc
14.3%
view
B
2020-02-14 16:00:12.0
Trillium Therapeutics Inc
n/a
Sio Capital Management
9.81%
view
S
2020-02-14 10:31:27.0
Trillium Therapeutics Inc
n/a
Matrix Capital Management Company
0.0%
view
B
2020-02-13 14:25:14.0
Trillium Therapeutics Inc
n/a
Growth Equity Opportunities V
2.59%
view
B
2020-02-03 16:31:05.0
Trillium Therapeutics Inc
n/a
Vivo Capital IX
4.9%
view
S
2020-01-21 16:52:59.0
Trillium Therapeutics Inc
n/a
Venrock Healthcare Capital Partners III
9.95%
view
B
2019-12-31 16:24:15.0
Trillium Therapeutics Inc
n/a
MORGAN STANLEY
9.42%
view
S
2019-03-04 15:45:01.0
Trillium Therapeutics Inc
n/a
Growth Equity Opportunities V
0.0%
view
S
2019-02-14 14:39:03.0
Trillium Therapeutics Inc
n/a
Matrix Capital Management Company
3.5%
view
B
2019-01-10 15:39:17.0
Trillium Therapeutics Inc
n/a
AWM Investment Company
5.3%
view
B
2018-02-13 16:26:03.0
Trillium Therapeutics Inc
n/a
BAKER BROS
9.99%
view
B
2018-02-06 16:12:22.0
Trillium Therapeutics Inc
n/a
Growth Equity Opportunities V
2.59%
view
S
2017-06-05 16:15:52.0
Trillium Therapeutics Inc
n/a
Cormorant Asset Management
0.0%
view
S
2017-02-13 16:38:51.0
Trillium Therapeutics Inc
n/a
Mottola Thomas D
7.3%
view
B
2017-02-01 17:03:42.0
Trillium Therapeutics Inc
n/a
JANUS CAPITAL MANAGEMENT LLC
7.5%
view
B
2016-02-16 14:41:11.0
Trillium Therapeutics Inc
n/a
Mottola Thomas D
7.5%
view
S
2016-02-16 08:18:30.0
Trillium Therapeutics Inc
n/a
Flynn James E
2.7%
view
B
2016-02-10 16:32:51.0
Trillium Therapeutics Inc
n/a
Stebbins James Henry DeGraff
n/a
view
B
2015-04-23 16:20:19.0
Trillium Therapeutics Inc
n/a
Ridgeback Capital Investments L
6.9%
view
B
2015-03-20 11:54:35.0
Trillium Therapeutics Inc
n/a
Mottola Thomas D
n/a
view
B
2015-02-23 15:45:33.0
Trillium Therapeutics Inc
n/a
Opaleye Management Inc
5.19%
view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.